Codiak Announces Pricing of $57.8 Million Public Offering of Common Stock

NEXT STORY
Talis Announces Pricing of Initial Public Offering
PREV STORY
Applied Therapeutics, Inc. Announces Pricing of Public Offering of 3,000,000 Shares of Common Stock
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Codiak Announces Pricing of $57.8 Million Public Offering of Common Stock

NEXT STORY
Talis Announces Pricing of Initial Public Offering
PREV STORY
Applied Therapeutics, Inc. Announces Pricing of Public Offering of 3,000,000 Shares of Common Stock
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Allena Pharmaceuticals Highlights Ongoing Efforts to Address Rare and Severe Metabolic Disorders Affecting the Kidney with Presentations at Upcoming Medical Meetings

NEWTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, ...

author_avatar
NASDAQ Market News

Corvus Pharmaceuticals to Present at the 2017 Wedbush PacGrow Healthcare Conference

BURLINGAME, Calif., Aug. 11, 2017 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq:CRVS), a clinical-stage ...

author_avatar
NASDAQ Market News

XBiotech Announces Successful Completion of GMP Audit

First Audit in Company’s New Manufacturing Facility Shows Compliance with GMP GuidelinesAUSTIN, Texas, Dec. ...

author_avatar
NASDAQ Market News